-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The production process of 2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetonitrile, also known as CX-11, involves several steps that must be carefully controlled to ensure that the final product meets the desired specifications.
- Synthesis of Hydroxyproline: Hydroxyproline is the starting material for the synthesis of CX-11.
It is synthesized through a multi-step process that involves the reaction of L-proline with formaldehyde in the presence of a strong acid catalyst. - Condensation of Hydroxyproline with Acetic Anhydride: The next step in the synthesis of CX-11 involves the condensation of hydroxyproline with acetic anhydride in the presence of a strong acid catalyst.
This reaction results in the formation of N-(1,2,3,5,6,7-hexahydro-2H-pyrrolizin-8-yl)-acetamide. - Reduction of N-(1,2,3,5,6,7-hexahydro-2H-pyrrolizin-8-yl)-acetamide: The N-(1,2,3,5,6,7-hexahydro-2H-pyrrolizin-8-yl)-acetamide obtained from the previous step is reduced to N-(1,2,3,5,6,7-hexahydro-2H-pyrrolizin-8-yl)acetonitrile using a reducing agent such as lithium aluminum hydride (LiAlH4).
- Purification of N-(1,2,3,5,6,7-hexahydro-2H-pyrrolizin-8-yl)acetonitrile: The N-(1,2,3,5,6,7-hexahydro-2H-pyrrolizin-8-yl)acetonitrile obtained from the reduction step is purified by crystallization, filtration, and recrystallization.
- Characterization of CX-11: The purified CX-11 is characterized by various analytical techniques such as spectroscopy, chromatography, and mass spectrometry to ensure that it meets the desired specifications.
- Scale-up of the Production Process: The final step involves scale-up of the production process to produce commercial quantities of CX-11.
This involves the use of larger reaction vessels, more efficient mixing equipment, and improved control systems to ensure consistent quality and yield.
In conclusion, the production process of CX-11 involves several steps that require careful control and characterization to ensure that the final product meets the desired specifications.
The synthesis of hydroxyproline and the condensation of hydroxyproline with acetic anhydride are the key steps in the synthesis of CX-11.
The reducing step reduces N-(1,2,3,5,6,7-hexahydro-2H-pyrrolizin-8-yl)-acetamide to N-(1,2,3,5,6,7-hexahydro-2H-pyrrolizin-8-yl)acetonitrile, which is then purified by crystallization, filtration, and recrystallization.
Characterization of CX-11 is done by various analytical techniques to ensure its quality and purity, and the production process is scaled up to produce commercial quantities of CX-11.